An interventional study of Early discharge with remote home monitoring. in Acute Pancreatitis, Telemedicine and Healthdot, sponsored by Rijnstate Hospital. Status unknown at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-08-15.
Sponsored by Rijnstate Hospital · Not applicable, Interventional, and Other
Acute pancreatitis is an inflammation of the pancreas which causes abdominal pain and is the most common gastro-intestinal reason for acute hospitalization in Western countries. Because care for a mild acute pancreatitis is supportive, early discharge of patients with a predicted mild course of acute pancreatitis might be safe with the use of remote home monitoring. This might reduce the demand for hospital beds and allow patients to benefit from recovering in their home environment. Therefore, the aim of this study is to assess the feasibility of a novel care pathway in which patients with a predicted mild course of acute pancreatitis are discharged early with remote home monitoring.
752 studies on the registry are indexed under Pancreatitis; 181 are open to participants now.
This study's planned enrollment of 70 is below the median of 80 across 448 interventional studies indexed under Pancreatitis.
Browse Pancreatitis studies →Rijnstate Hospital is the lead sponsor of 127 studies on the registry; 14 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Have 2 out of 3 revised Atlanta criteria for pancreatitis:
Exclusion Criteria:
Signs of severe pancreatitis at the moment of admission to the GE ward:
More than one SIRS criteria:
Have one or more of the following comorbidities:
* Patients are discharged early * Patients receive remote home monitoring using a wearable sensor and a smartphone app. * Patients fill in a satisfaction questionnaire
Other: Early discharge with remote home monitoring.
After at least 48 hours of hospital admission, patients are discharged early with the use of remote home monitoring. During home monitoring, heartrate, respiratory rate, posture and movement are monitored every 5 minutes for at least 4 days, using a wearable sensor. Core temperature is monitored using an ear thermometer. Patients are contacted once per day by a nurse from the Virtual Monitoring Centre (VMC) to assess pancreatitis related complaints, intake of fluids and food, pain and the use of analgesics. Patients are asked to provide information to the hospital using a smartphone app.
Incidence (%) of unplanned hospital readmissions.
To determine the feasibility of novel care pathway
Time frame: Within 30 days of discharge
2. Incidence (%) of pancreatitis related complications. These complications include necrotizing pancreatitis, infection, pseudocysts, new onset diabetes, recurrence of pancreatitis, cholecystitis or cholangitis.
To determine the feasibility of novel care pathway
Time frame: Within 30 days of discharge
3. Mortality (%) of patients discharged home with remote monitoring.
To determine the feasibility of novel care pathway
Time frame: Within 30 days of discharge
Length of stay in the hospital
Time frame: Within 30 days of discharge.
The amount of extra contacts between VMC-nurse or physician and the patient, in addition to the usual call once per day as documented in the smartphone app.
Time frame: Within 30 days of discharge
The amount of laboratory or imaging tests
All bloodtests and imaging tests (US, MRI and CT-scan will be documented)
Time frame: Within 30 days of discharge
Amount of adjustments in analgesics needed during home monitoring
Time frame: Within 30 days of discharge
Patient satisfaction is assessed using a satisfaction questionnaire
Using a combination of two validated questionnaires
Time frame: After 14 days of discharge.
Overall costs of treatment
Time frame: Within 30 days of discharge
Plan to share: Yes
No publications or documents are linked to this record.
This study is status unknown, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rijnstate Hospital